Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × Fulvestrant × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 32 Neoplasm Metastasis 5 Ovarian Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Endometrial Neoplasms 2 Advanced Breast Cancer 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Recurrence 1 Multiple Endocrine Neoplasia Type 1 1 Lung Neoplasms 1 Locoregional Recurrence 1 HR-positive, HER2-negative Advanced Breast Cancer 1 HR+/HER2- Breast Cancer 1 Fallopian Tube Neoplasms 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Esophageal Squamous Cell Carcinoma 1 Disease Progression 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Ovarian Epithelial 1 Anatomic Stage III Breast Cancer AJCC v8 1 Advanced Unresectable or Metastatic Breast Cancer of Adults 1 Advanced Solid Tumor 1

Interventions

Gemcitabine 7 Cisplatin 6 durvalumab 5 pembrolizumab 4 Oxaliplatin 3 Bevacizumab 3 lenvatinib 2 S 1 (combination) 2 Leucovorin 2 Injections 2 Folfox protocol 2 Capecitabine 2 Albumin-Bound Paclitaxel 2 zanidatamab 1 trastuzumab deruxtecan 1 gemcitabine-oxaliplatin regimen 1 envafolimab 1 atezolizumab 1 Trastuzumab 1 Tegafur 1 Nivolumab 1 Irinotecan 1 Infusions, Intravenous 1 Immune Checkpoint Inhibitors 1 Docetaxel 1 Carboplatin 1 CA-4948 1 Antibodies 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡